Entities Organizations Interius BioTherapeutics
Organization · Biotech
Last updated 2026-04-10
ConfirmedInterius BioTherapeutics
Interius BioTherapeutics is a clinical-stage biotechnology company engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases in oncology, autoimmunity, and beyond. The company's proprietary LENTIVECTOR platform enables in vivo generation of CAR T and CAR NK cells through a single intravenous infusion, offering a potential off-the-shelf, scalable alternative to traditional ex vivo cell therapies.
Not to be confused with similarly named companies; this entity is a biotechnology firm focused on in vivo cell and gene therapy. Acquired by Kite, a Gilead Company.
Same as
Extended Facts
Relationships
People
Products
Verified Profiles
Cross-platform entity consensus: 2 independent sources
SameAs links connect this entity to its canonical presence across authoritative platforms.